Prohibited Substances in Cosmetic Products

(
[
1
2
3
4
5
6
7
8
9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
T
U
V
W
X
Y
Z

Chemical name / INN
CAS number
EC number

Triamterene (INN) and its salts
396-01-0
206-904-3

Tributyl phosphate
126-73-8
204-800-2

Trichlormethine (INN) and its salts
555-77-1 / 817-09-4
- / 212-442-3 / -

Trichloroacetic acid
76-03-9
200-927-2

Trichloroethylene
79-01-6
201-167-4

Trichloronitromethane (chloropicrine)
76-06-2
200-930-9

Tridemorph
24602-86-6
246-347-3

Trifluoroiodomethane
2314-97-8
219-014-5

Trifluperidol (INN)
749-13-3
-

Trinickel disulfide; nickel subsulfied [1]; heazlewoodite [2]
12035-72-2 [1] / 120
234-829-6 [1] / - [2

Trioxymethylene (1,3,5 -Trioxan)
110-88-3
203-812-5

Triparanol (INN)
78-41-1
201-115-0

Tripelennamine (INN)
91-81-6
202-100-1

tris(2 -Chloroethyl) phosphate
115-96-8
204-118-5

Trisodium [4' -(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II)
413-590-3

Trisodium 3 -hydroxy-4-(4'-sulphonatonaphthylazo)naphthalene-2,7-disulphonate (Acid Red 27; CI 16185) when used as a substance in hair dye products
915-67-3
213-022-2

Trisodium 8 -hydroxypyrene-1,3,6-trisulphonate (Solvent Green 7; CI 59040) when used as a substance in hair dye products
6358-69-6
228-783-6

Trisodium bis(7 -acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulfonato-1-naphtholato)chromate(1-)
400-810-8

Trisodium tris[5,6 -dihydro-5-(hydroxyimino)-6-oxonaphthalene-2-sulphonate(2-)-N5,O6]ferrate(3-); (Acid Green 1; CI 10020) when used as a substance in hair dye products
19381-50-1
243-010-2

Tritolyl phosphate
1330-78-5
215-548-8

Tuaminoheptane (INN), its isomers and salts
123-82-0
204-655-5

Urethane (Ethyl carbamate)
51-79-6
200-123-1

Urginea scilla Steinh. and its galenical preparations
84650-62-4
283-520-2

UVCB condensation product of: tetrakis -hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine
166242-53-1
422-720-8

Vaccines, toxins or serums defined as immunological medicinal products pursuant to Article 1(4) of Directive 2001/83/EC